Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin as an adjunct in limb reconstruction to reduce pain and joint complications during bone lengthening
2008-000853-37Phase 4Terminated
- Sponsor
- Sheffield Children's Hospital
- Start
- Oct 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of neuronox in Femoral Deformity, Tibial deformity and Congenital talipes equinovarus (CTEV), sponsored by Sheffield Children's Hospital. Primary endpoint: Pain levels during lengthening phase. Started Oct 2008; status: terminated.
02
Drugs
neuronox
03
Conditions
Femoral DeformityTibial deformityCongenital talipes equinovarus (CTEV)
Beyond the preview
Go deeper on 2008-000853-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000853-37.